DOI:
10.1055/s-00000054
Pharmacopsychiatry
LinksClose Window
References
Xiang Q, Zhao X, Zhou Y. et al.
Effect of CYP2D6, CYP3A5, and MDR1 genetic polymorphisms on the pharmacokinetics of risperidone and its active moiety.
J Clin Pharmacol 2010;
50: 659-666
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.